Kenta Nio

<scp>PD</scp>‐1+ <scp>TIM</scp>‐3+ T cells in malignant ascites predict prognosis of gastrointestinal cancer

Michitaka Nakano, Mamoru Ito, Risa Tanaka et al. · Cancer Science · 2018 · 45 citations · Full text

Life Sciences, Immunology, Oncology +17

Bi-cytopenia possibly induced by anti-PD-1 antibody for primary malignant melanoma of the esophagus

Kyoko Inadomi, Hozumi Kumagai, Shuji Arita et al. · Medicine · 2016 · 38 citations · Full text

Medicine, Oncology, Pharmacology +17

A multicenter propensity score analysis of FOLFIRINOX vs gemcitabine plus nab-paclitaxel administered to patients with metastatic pancreatic cancer: results from the NAPOLEON study

Taiga Otsuka, Tsuyoshi Shirakawa, Mototsugu Shimokawa et al. · International Journal of Clinical Oncology · 2021 · 26 citations

Medicine, Oncology, Pharmacology +11

Pancreatic acinar cell carcinoma presenting with panniculitis, successfully treated with FOLFIRINOX: A case report

Tomoyasu Yoshihiro, Kenta Nio, Kenji Tsuchihashi et al. · Molecular and Clinical Oncology · 2017 · 24 citations · Full text

Medicine, Oncology, Pathology +17

Gemcitabine plus nab-paclitaxel in older patients with metastatic pancreatic cancer: A post-hoc analysis of the real-world data of a multicenter study (the NAPOLEON study)

Futa Koga, Yasunori Kawaguchi, Mototsugu Shimokawa et al. · Journal of Geriatric Oncology · 2021 · 21 citations

Medicine, Oncology, Pharmacology +15